Kestra Medical Technologies, Ltd. (KMTS)
NASDAQ: KMTS · Real-Time Price · USD
25.00
+1.57 (6.70%)
Mar 31, 2025, 3:55 PM EDT - Market open

KMTS Income Statement

Millions USD. Fiscal year is May - Apr.
Fiscal Year
TTM FY 2024 FY 2023 FY 2021 FY 2020
Period Ending
Oct '24 Apr '24 Apr '23 Apr '21 Apr '20
Revenue
45.8227.817.63--
Revenue Growth (YoY)
-264.54%---
Cost of Revenue
33.5227.4518.28--
Gross Profit
12.310.36-10.65--
Selling, General & Admin
75.769.9454.0113.96.52
Research & Development
14.4715.4915.7618.8122.8
Operating Expenses
90.1785.4369.7732.7129.32
Operating Income
-77.86-85.06-80.42-32.71-29.32
Interest Expense
-6.86-6.23-5.63-1.17-
Other Non Operating Income (Expenses)
-0.12-0.091.83-0.04-
EBT Excluding Unusual Items
-84.85-91.38-84.22-33.91-29.32
Other Unusual Items
--2.72---
Pretax Income
-84.85-94.1-84.22-33.91-29.32
Income Tax Expense
00.020.020.190.15
Net Income
-84.16-94.12-84.24-34.1-29.47
Preferred Dividends & Other Adjustments
9.516.722.5--
Net Income to Common
-93.67-100.84-86.74-34.1-29.47
Shares Outstanding (Basic)
00000
Shares Outstanding (Diluted)
00000
EPS (Basic)
-885.25-953.06-819.76-322.29-278.50
EPS (Diluted)
-885.25-953.06-819.76-322.29-278.50
Free Cash Flow
-86.92-84.75-85.1-30.23-30.53
Free Cash Flow Per Share
-821.51-800.97-804.32-285.72-288.49
Gross Margin
26.86%1.30%-139.59%--
Operating Margin
-169.91%-305.83%-1054.01%--
Profit Margin
-204.41%-362.56%-1136.79%--
Free Cash Flow Margin
-189.69%-304.70%-1115.37%--
EBITDA
-66.75-73.5-75.57-32.29-28.84
EBITDA Margin
-145.67%-264.27%---
D&A For EBITDA
11.1111.564.860.420.48
EBIT
-77.86-85.06-80.42-32.71-29.32
Updated Feb 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q